DE60129719D1 - Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen - Google Patents

Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen

Info

Publication number
DE60129719D1
DE60129719D1 DE60129719T DE60129719T DE60129719D1 DE 60129719 D1 DE60129719 D1 DE 60129719D1 DE 60129719 T DE60129719 T DE 60129719T DE 60129719 T DE60129719 T DE 60129719T DE 60129719 D1 DE60129719 D1 DE 60129719D1
Authority
DE
Germany
Prior art keywords
proteins
compounds
relates
phosphodiesterase
pde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60129719T
Other languages
English (en)
Other versions
DE60129719T2 (de
Inventor
Robert Margolskee
Joseph Beavo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Icahn School of Medicine at Mount Sinai
Original Assignee
University of Washington
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Mount Sinai School of Medicine filed Critical University of Washington
Publication of DE60129719D1 publication Critical patent/DE60129719D1/de
Application granted granted Critical
Publication of DE60129719T2 publication Critical patent/DE60129719T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60129719T 2000-09-14 2001-09-14 Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen Expired - Fee Related DE60129719T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23255200P 2000-09-14 2000-09-14
US232552P 2000-09-14
PCT/US2001/028663 WO2002022649A2 (en) 2000-09-14 2001-09-14 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity

Publications (2)

Publication Number Publication Date
DE60129719D1 true DE60129719D1 (de) 2007-09-13
DE60129719T2 DE60129719T2 (de) 2008-06-05

Family

ID=22873601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129719T Expired - Fee Related DE60129719T2 (de) 2000-09-14 2001-09-14 Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen

Country Status (9)

Country Link
US (1) US7179614B2 (de)
EP (1) EP1317564B1 (de)
AT (1) ATE368750T1 (de)
AU (1) AU2002211228A1 (de)
CA (1) CA2421938A1 (de)
DE (1) DE60129719T2 (de)
DK (1) DK1317564T3 (de)
ES (1) ES2291362T3 (de)
WO (1) WO2002022649A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158488A0 (en) * 2001-04-20 2004-05-12 Sinai School Medicine Tir3 a novel taste receptor
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20050260258A1 (en) 2003-12-18 2005-11-24 The Texas A&M University System Use of vitelline protein B as a microencapsulating additive
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
US20160045617A1 (en) * 2013-04-10 2016-02-18 Justin C. Lee Treatment of proximal spinal muscular atrophy

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
IL92124A (en) 1988-10-28 1996-10-31 Sidney Pestka Recombinant proteins modified to contain post-phosphorylation that do not occur in nature
DK0460323T3 (da) * 1990-06-06 1993-12-27 Propper Mfg Co Inc Biologisk sterilisationstestpakning
US5783682A (en) 1990-07-27 1998-07-21 Isis Pharmaceuticals, Inc. Oligonucleotide mimics having nitrogen-containing linkages
US5677437A (en) 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5792844A (en) 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
EP0550553B1 (de) 1990-09-25 2000-07-12 Cantab Pharmaceuticals Research Limited Bei einer transkomplementenden zellinie erzeugter defektiver virenimpfstoff
US5217889A (en) 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements
ATE250629T1 (de) 1991-04-19 2003-10-15 Univ Washington Für säugetierphosphodiesterasen kodierende dns
US6008000A (en) * 1992-04-09 1999-12-28 Linguagen Corporation Gustducin materials and methods
US5817759A (en) * 1992-04-09 1998-10-06 Linguagen Corporation Gustducin polypeptides and fragments
US5281400A (en) * 1992-09-30 1994-01-25 Carr Metal Products Plastic autoclave tray and lid combination
JPH08507784A (ja) 1993-03-19 1996-08-20 キャンタブ ファーマシューティカルズ リサーチ リミティド ウイルス・ワクチン
PT652960E (pt) 1993-05-27 2001-08-30 Icos Corp Materiais para fosfodiesterases especificas e de ligacao do mpg ciclico e respectivos metodos
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
EP0753069A1 (de) 1994-04-15 1997-01-15 Targeted Genetics Corporation Fusionsprotein für Gentransfer
CA2188950C (en) * 1994-04-26 2001-07-03 James R. Broach Functional expression of mammalian adenylyl cyclase in yeast
CA2135253A1 (en) * 1994-11-07 1996-05-08 Michael Dennis Compound screening based on a window of chemical-messenger-independent activity
WO1997014709A1 (en) 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Antisense oligomers
US5814500A (en) 1996-10-31 1998-09-29 The Johns Hopkins University School Of Medicine Delivery construct for antisense nucleic acids and methods of use
BR9816342B1 (pt) * 1997-05-23 2012-06-26 cámara de incubação para um aparelho de teste microbiológico diagnóstico.
US5834313A (en) * 1997-09-19 1998-11-10 Johnson & Johnson Medical, Inc. Container monitoring system
US6815206B2 (en) * 1997-09-19 2004-11-09 Ethicon, Inc. Container monitoring system
US6355448B1 (en) * 1998-06-02 2002-03-12 3M Innovative Properties Company Sterilization indicator with chemically stabilized enzyme
WO2000027861A1 (en) * 1998-11-12 2000-05-18 The Board Of Trustees Of The Leland Stanford Junior University Novel phosphodiesterase interacting proteins
GB9927331D0 (en) * 1999-11-18 2000-01-12 Fluorescience Ltd Assay for measuring enzyme activity in vivo
JP2004512019A (ja) * 2000-06-22 2004-04-22 インサイト・ゲノミックス・インコーポレイテッド ホスホジエステラーゼ
JP2005526670A (ja) * 2001-10-24 2005-09-08 パクティブ コーポレイション 食肉品を低酸素濃度環境で包装するシステム及び方法

Also Published As

Publication number Publication date
EP1317564A4 (de) 2005-01-19
EP1317564A2 (de) 2003-06-11
DK1317564T3 (da) 2007-12-03
CA2421938A1 (en) 2002-03-21
DE60129719T2 (de) 2008-06-05
ATE368750T1 (de) 2007-08-15
WO2002022649A3 (en) 2002-05-30
EP1317564B1 (de) 2007-08-01
AU2002211228A1 (en) 2002-03-26
US7179614B2 (en) 2007-02-20
ES2291362T3 (es) 2008-03-01
WO2002022649A2 (en) 2002-03-21
US20040063148A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
DE69926248D1 (de) Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen
BR9912437A (pt) ácidos nucléicos codificando um receptor ligado à proteìna g envolvido na transdução sensória
DE60215626D1 (de) Antagonist für die multimerisierung von hiv-1 vif-protein
WO2000021987A3 (en) A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
DK1864131T3 (da) Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
MXPA04001287A (es) Ensayo de receptor unido a proteina g.
ATE212065T1 (de) Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
ATE283481T1 (de) Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten
DE60129719D1 (de) Screening-verfahren zum identifizieren von g-proteinen und anderen verbindungen,die die phosphodiesterase (pde)-aktivität beeinflussen
ATE393394T1 (de) Verfahren zum nachweis von proteinen, die miteinander interagieren
ATE288589T1 (de) Verfahren zur analyse von proteinen
AU2003293959A1 (en) Millisecond activation switch for seven-transmembrane proteins
WO2002036773A3 (en) Nod2 nucleic acids and proteins
WO2002042458A3 (en) G protein coupled receptors
WO2002000719A3 (en) Human and mouse g-protein couipled receptors
WO2004090103A3 (en) Identification of novel nogo-receptors and methods related thereto
AU5722499A (en) G protein-coupled receptor agonists or antagonists
ATE462721T1 (de) Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren
ATE412187T1 (de) Screening test
SE9701010D0 (sv) Antibody
DE60120942D1 (de) Verbessertes verfahren für reverses n-hybrid-screening
DE602004015468D1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
WO2004053142A3 (en) P53-associated parkin-like cytoplasmic protein, and related compositions and methods
DE69926624D1 (de) Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee